New Year Present For Takeda As Shire Close Nears?
Takeda is hoping to start 2019 with a bang, saying its huge acquisition of Shire might become a done deal as early as January 8. Speculation continues meanwhile on possible post-merger divestments to help pay down associated debt.
You may also be interested in...
Takeda may have to shed a Shire late-stage pipeline asset to meet European anti-competition concerns around the companies' planned merger, although the process is not expected to derail the deal's timing.
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.
Japanese ophthalmic specialist picks up young private US firm and gains a small but broad set of marketed products.